Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors.
暂无分享,去创建一个
K. McGaughey | M. Epstein | L. Golestaneh | W. Benton | Paula J. Alvarez | N. Reaven | S. Funk | M. Brenner
暂无分享,去创建一个
K. McGaughey | M. Epstein | L. Golestaneh | W. Benton | Paula J. Alvarez | N. Reaven | S. Funk | M. Brenner